Are underlying assumptions of current animal models of human stroke correct: from STAIRS to high hurdles? Transl Stroke Res 2: 138-143

Author(s): Turner RJ, Jickling GC, Sharp FR


Animal models of acute ischemic stroke have been criticized for failing to translate to human stroke. Nevertheless, animal models are necessary to improve our understanding of stroke pathophysiology and to guide the development of new stroke therapies. The rabbit embolic clot model is one animal model that has led to an effective therapy in human acute ischemic stroke, namely tissue plasminogen activator (tPA). We propose that potential compounds that demonstrate efficacy in non-rabbit animal models of acute ischemic stroke should also be tested in the rabbit embolic blood clot model and, where appropriate, compared to tPA prior to investigation in humans. Furthermore, the use of anesthesia needs to be considered as a major confounder in animal models of acute ischemic stroke, and death should be included as an outcome measure in animal stroke studies. These steps, along with the current STAIRs recommendations, may improve the successful translation of experimental therapies to clinical stroke treatments.

Similar Articles

Ischemic stroke subtypes: a population-based study of incidence and risk factors

Author(s): Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, et al.

Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence

Author(s): Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, et al.

Thrombolysis with alteplase 3 to 4

Author(s): Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, et al.

The science of stroke: mechanisms in search of treatments

Author(s): Moskowitz MA, Lo EH, Iadecola C

von Willebrand factor: an emerging target in stroke therapy

Author(s): De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C

Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins

Author(s): André P, Denis CV, Ware J, Saffaripour S, Hynes RO, et al.

Shear-dependent changes in the three-dimensional structure of human von Willebrand factor

Author(s): Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, et al.

Deficiency of von Willebrand factor protects mice from ischemic stroke

Author(s): Kleinschnitz C, De Meyer SF, Schwarz T, Austinat M, Vanhoorelbeke K, et al.

Tissue plasminogen activator reduces neurological damage after cerebral embolism

Author(s): Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA

Tissue plasminogen activator

Author(s): Zivin JA, Lyden PD, DeGirolami U, Kochhar A, Mazzarella V, et al.

Quantal bioassay and stroke

Author(s): Zivin JA, Waud DR

Neuroprotective effects of anesthetic agents

Author(s): Kawaguchi M, Furuya H, Patel PM